InnoCare Pharma Limited (HKG:9969)

Hong Kong · Delayed Price · Currency is HKD

15.72

-0.11 (-0.69%)

Apr 17, 2026, 3:45 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	2.37B	1.01B	738.54M	625.40M	1.04B
Pharmaceuticals Growth	135.27%	36.68%	18.09%	-40.04%	76368.70%
Total	2.37B	1.01B	738.54M	625.40M	1.04B
Total Growth	135.27%	36.68%	18.09%	-40.04%	76368.70%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	1.44B	1.01B	673.13M	-	-
China Growth	43.17%	49.33%	-	-	-
Foreign	935.79M	4.24M	65.40M	57.37M	826.97M
Foreign Growth	21977.84%	-93.52%	14.00%	-93.06%	-
Mainland China	-	-	-	568.04M	216.07M
Mainland China Growth	-	-	-	162.90%	15740.62%
Total	2.37B	1.01B	738.54M	625.40M	1.04B
Total Growth	135.27%	36.68%	18.09%	-40.04%	76368.70%

Source: S&P Global Market Intelligence.